Major corporations across North America and Europe are severing contracts and distancing themselves from U.S. Immigration and Customs Enforcement (ICE) following public backlash over the agency's enforcement tactics and recent fatal incidents.
Ford Motor Company is reportedly in preliminary discussions with Chinese tech and auto newcomer Xiaomi, exploring a joint venture that could facilitate Xiaomi's entry into U.S. vehicle manufacturing, according to sources familiar with the matter.
The latest release of court documents from the Jeffrey Epstein case has sent shockwaves through international corridors of power, revealing communications between the convicted sex offender and high-profile figures in India, Australia, the UK, Slovakia, and Norway, prompting resignations and fierce political denials.
Tesla's stock dipped amid reports of potential Ford-Xiaomi joint venture talks, highlighting growing competitive pressures from Chinese EV makers and the complex geopolitical landscape shaping the auto industry's future.
Hess Midstream Partners LP (HESM) signals a pivotal shift towards robust free cash flow generation, forecasting a 40% drop in capital expenditures for 2026 as its core system build-out concludes. Despite near-term weather headwinds, strong minimum volume commitments underpin financial targets through 2028.
IDEXX Laboratories reports robust fourth-quarter and full-year 2025 results, with double-digit revenue growth fueled by record instrument placements and strategic innovations like InVue DX and CancerDx. The company provides a confident outlook for 2026, targeting continued organic growth despite sector headwinds.
Walmart is launching a cross-border shipping initiative early this year, enabling U.S.-based third-party sellers to directly reach consumers in Mexico and Canada, intensifying its e-commerce competition with Amazon.
Buoyed by robust demand for its premium iPhone 17 Pro models, Apple is projected to report its highest quarterly iPhone sales increase in over four years. Analysts spotlight a pivotal AI deal with Google's Gemini as a key future growth lever, even as the tech giant navigates supply chain cost pressures.
In a strategic reversal, GSK has handed back global rights to the clinical-stage RNA editing drug WVE-006 to Wave Life Sciences. Wave asserts the move allows it to faster advance the potential 'functional cure' for alpha-1 antitrypsin deficiency, while GSK refocuses on broader respiratory markets.
Chinese biotech firm Arctic Vision moves to create an integrated ophthalmology powerhouse by acquiring MDCO Technology's device business, combining drug and device expertise to address unmet needs in eye care.
Amidst a cautious market climate, companies with substantial insider ownership often signal strong internal conviction. We examine three such firms—spanning South Korean tourism, Chinese sensors, and Taiwanese biopharma—where executives and directors have significant skin in the game.
Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing expansion for its weight-loss drugs and enters two strategic research collaborations in gene editing and immunology, signaling aggressive growth plans amid a recent stock valuation dip.
The UK's economic recovery faces a significant drag from recently implemented fiscal tightening, with growth forecasts remaining subdued for the coming year, according to a leading economic forecaster.
Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
OpenAI is reportedly in late-stage discussions to secure a colossal funding package, potentially nearing $40 billion, from its key partners and suppliers Nvidia, Amazon, and Microsoft, as the AI leader seeks capital for an ambitious global expansion.
A strategic report warns that recent tariff hikes could significantly increase clothing costs for American shoppers unless brands rapidly diversify production to a network of partner nations.
NetEase Cloud Music has entered a multi-year strategic partnership with Universal Music Group, securing licensing and distribution rights for UMG's vast catalog in China. The deal aims to expand music access for Chinese listeners while creating new global promotion channels for domestic talent.
Brookfield Business Partners reported a robust 2025, generating over $2 billion from asset sales, reducing debt, and making strategic acquisitions. The firm is on the cusp of a major corporate restructuring into a single listed entity, aiming to boost liquidity and investor appeal in a shifting global landscape.
The acquisition, set to finalize in early 2026 pending approvals, will merge European and American production powerhouses into an entity overseeing nearly 100 companies across 15 countries.
In a move set to redefine border and cargo operations, U.S. AI specialist BigBear.ai has partnered with Abu Dhabi's Maqta Technologies. The collaboration, unveiled at a major industry forum, aims to develop next-generation AI solutions for government agencies and port operators worldwide, focusing on efficiency and security.
